Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study
ConclusionXG-PP provided a comparable efficacy to hydrocortisone ointment in managing AD, thus representing a safe and effective steroid-sparing alternative in pediatric patients with AD.Trial RegistrationRetrospectively registered on 24 November 2021 in the ISRCTN registry: 11118799.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Children | Corticosteroid Therapy | Dermatitis | Dermatology | Eczema | Hydrocortisone | Pediatrics | Skin | Statistics | Study